caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1477581320

Jeffrey BakkeM.D.

PRACTICENORTH CLINIC, PASee all providers at this practice →
Family PracticeOsseo, MNI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
QUALITY · MIPS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
8,218
Beneficiaries
—
Total drug cost
$768K
Distinct drugs
99
Brand share
20.3%
Top prescribed drugs
Atorvastatin Calcium728 claims
Lisinopril483 claims
Amlodipine Besylate483 claims
Losartan Potassium415 claims
Metoprolol Succinate334 claims
REFERRAL NETWORK

Where Jeffrey Bakke's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 2 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
MAPLE GROVE HOSPITAL CORPORATION1125
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
NORTH MEMORIAL HEALTH CARE3488
NOONAN, DANIEL1146
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,249
Unique beneficiaries
—
Total services
1,706
Distinct HCPCS
23
Medicare payment
$51K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 2,349 Family Practice providers in MN — top quintile (cohort median 523).
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.